Arrowhead Pharmaceuticals, Inc. (ARWR)

63.84 -2.41 (-3.64%) USD  |  NASDAQ  |  Jan 16, 16:00
64.09 +0.25 (+0.39%) After-Hours: 20:00
More

Arrowhead Pharmaceuticals Current Portion of Long Term Debt (Quarterly)

Current Portion of Long Term Debt (Quarterly) Chart

View Current Portion of Long Term Debt (Quarterly) for ARWR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Portion of Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Portion of Long Term Debt (Quarterly) Range, Past 5 Years

View Current Portion of Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Portion of Long Term Debt (Quarterly) Benchmarks

View Current Portion of Long Term Debt (Quarterly) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. Upgrade
Eli Lilly & Co. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade
Celcuity, Inc. Upgrade